| Steven M Koch, PHD, LP | |
|
13460 Walsh Dr, Boys Town, NE 68010-7529 | |
| (531) 355-3358 | |
| (531) 355-3375 |
| Full Name | Steven M Koch |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 13460 Walsh Dr, Boys Town, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366555427 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 904 (Nebraska) | Primary |
| Entity Name | Father Flanagans Boys Home |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295821825 PECOS PAC ID: 9638165400 Enrollment ID: O20040426000622 |
News Archive
"ACP strongly believes in the goal of widespread adoption and use of health information technology to improve quality of care," Michael H. Zaroukian, MD, PhD, FACP, told the National Committee on Vital and Health Statistics subcommittee on Privacy and Confidentiality at their hearing on "Consumer Controls for Sensitive Health Records."
Johnson and Johnson's experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.
Protecting the wealth of older adults should be a high priority for banks, insurance companies, and others, according to the latest edition of Public Policy & Aging Report (PP&AR). Elder financial exploitation and diminished financial capacity resulting from age-related cognitive impairments both pose major economic threats, the issue finds.
EpiCept Corporation today announced that the Israeli Ministry of Health has approved the marketing application for Ceplene®, indicated for remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. Megapharm Ltd. is EpiCept's partner in Israel and upon Ministry of Health approval of labeling and other technical matters the company is expected to launch Ceplene® in the first quarter of 2011.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven M Koch, PHD, LP 13460 Walsh Dr, Boys Town, NE 68010-7529 Ph: (531) 355-3358 | Steven M Koch, PHD, LP 13460 Walsh Dr, Boys Town, NE 68010-7529 Ph: (531) 355-3358 |
News Archive
"ACP strongly believes in the goal of widespread adoption and use of health information technology to improve quality of care," Michael H. Zaroukian, MD, PhD, FACP, told the National Committee on Vital and Health Statistics subcommittee on Privacy and Confidentiality at their hearing on "Consumer Controls for Sensitive Health Records."
Johnson and Johnson's experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.
Protecting the wealth of older adults should be a high priority for banks, insurance companies, and others, according to the latest edition of Public Policy & Aging Report (PP&AR). Elder financial exploitation and diminished financial capacity resulting from age-related cognitive impairments both pose major economic threats, the issue finds.
EpiCept Corporation today announced that the Israeli Ministry of Health has approved the marketing application for Ceplene®, indicated for remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. Megapharm Ltd. is EpiCept's partner in Israel and upon Ministry of Health approval of labeling and other technical matters the company is expected to launch Ceplene® in the first quarter of 2011.
› Verified 5 days ago
Dr. Thomas M Reimers, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 13460 Walsh Dr, Boys Town, NE 68010 Phone: 402-498-3358 Fax: 402-498-3375 | |
Patrick Friman, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 13460 Walsh Dr, Boys Town, NE 68010 Phone: 402-498-3358 Fax: 402-498-3375 | |
Oliver George Johnston, MS Psychologist Medicare: Medicare Enrolled Practice Location: 13460 Walsh Dr, Boys Town, NE 68010 Phone: 531-355-3358 Fax: 531-355-3375 | |
Kimberly A Haugen, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 13460 Walsh Dr, Boys Town, NE 68010 Phone: 402-498-3358 Fax: 402-498-3375 | |
Dr. Amy Linn Turner, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 13460 Walsh Dr, Boys Town, NE 68010 Phone: 402-498-3358 Fax: 402-498-3375 | |
Jamarri Ramon Aikins, PHD, LP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 13460 Walsh Dr, Boys Town, NE 68010 Phone: 402-498-3358 Fax: 402-498-3375 |